Literature DB >> 26671553

The role of microRNAs in the adrenocortical carcinomas.

Xin Yu1, Zheng Li2.   

Abstract

MicroRNAs (miRNAs) are a group of small, non-protein-coding RNAs that inhibit gene expressions through binding their 3'-UTR regions. Each miRNA can regulate a number of target genes and play crucial roles in a lot of biological processes including organogenesis, hematopoiesis, cell development, proliferation, and invasion. Deregulated expression of miRNAs has been found to be associated with initiation and development of tumors. Increasing evidences showed that miRNAs play a crucial role in adrenocortical carcinomas (ACCs). Aberrant miRNA expression may contribute to ACC carcinogenesis, and it can act as tumor-suppressive or oncogenic miRNAs. In this review, we reviewed the recent studies available on ACC-associated miRNAs. We try to summarize the contribution of miRNAs to the initiation and development of ACCs.

Entities:  

Keywords:  Adrenocortical carcinomas; MiR-7; MiRNAs; microRNAs

Mesh:

Substances:

Year:  2015        PMID: 26671553     DOI: 10.1007/s13277-015-4630-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

1.  Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.

Authors:  Santosh Kumar Mondal; Senjuti Dasgupta; Parul Jain; Palash Kumar Mandal; Swapan Kumar Sinha
Journal:  J Cancer Res Ther       Date:  2013 Jul-Sep       Impact factor: 1.805

2.  Clinical impact of TP53 alterations in adrenocortical carcinomas.

Authors:  Jens Waldmann; Nikolaos Patsalis; Volker Fendrich; Peter Langer; Wolfgang Saeger; Brunhilde Chaloupka; Annette Ramaswamy; Martin Fassnacht; Detlef K Bartsch; Emily P Slater
Journal:  Langenbecks Arch Surg       Date:  2011-12-29       Impact factor: 3.445

3.  Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial.

Authors:  J Hubertus; N Boxberger; A Redlich; D von Schweinitz; P Vorwerk
Journal:  Klin Padiatr       Date:  2012-04-13       Impact factor: 1.349

4.  Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas?

Authors:  Kelsey A Flynt; Jonathan R Dillman; Matthew S Davenport; Ethan A Smith; Tobias Else; Peter J Strouse; Elaine M Caoili
Journal:  Pediatr Radiol       Date:  2015-03-21

5.  MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.

Authors:  Erin E Patterson; Alisha K Holloway; Julie Weng; Tito Fojo; Electron Kebebew
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

Review 6.  MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Liu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-23       Impact factor: 6.831

Review 7.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

Review 8.  The role of microRNAs expression in laryngeal cancer.

Authors:  Xin Yu; Zheng Li
Journal:  Oncotarget       Date:  2015-09-15

9.  Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.

Authors:  Cuiping Wang; Yang Sun; Huanwen Wu; Dachun Zhao; Jie Chen
Journal:  Histopathology       Date:  2013-11-23       Impact factor: 5.087

Review 10.  The role of miRNAs in cutaneous squamous cell carcinoma.

Authors:  Xin Yu; Zheng Li
Journal:  J Cell Mol Med       Date:  2015-10-27       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.